Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand the role and functions of genes and chromosomes. It plays a crucial role in the early diagnosis of a disease, identification of genetic tendency to cause disease, and prediction of an individual’s reaction to drugs. The FISH and aCGH play a prominent role in molecular cytogenetics technology. It involves the screening and diagnostic tests that are used for determining the complex interaction of genes and chromosomes to assess the status of a disease. In addition, molecular cytogenetics is mainly used in the R&D activities of research laboratories for drug discovery, identification of biomarkers, and screening drug candidates that react to these biomarkers.
Analysts forecast the Global Molecular Cytogenetics Market will grow at a CAGR of 23.51 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Molecular Cytogenetics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used in molecular cytogenetics. The products employed in the use of FISH and aCGH techniques are considered within the
Scope of the report.
Global Molecular Cytogenetics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Molecular Cytogenetics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
Purchase a copy of the report at http://www.sandlerresearch.org/purchase?rname=19073
- Abbott Laboratories
- Affymetrix Inc.
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd
- Illumina Inc.
- PerkinElmer Inc.
Other Prominent Vendors
- Applied Spectral Imaging Ltd
- Biological Industries Ltd
- Bio-Rad Laboratories Inc.
- Cytognomix Inc.
- CytoTest Inc.
- Illumina Inc.
- Kreatech Inc.
- Leica Biosystems Ltd
- Life Technologies Corp.
- Oxford Gene Technology Ltd
- SciGene Corp.
Key Market Driver
- Increasing Incidence of Genetic Disorders.
Key Market Challenge
- Ethical and Social Constraints.
Key Market Trend
- Increased Preference of Personalized Medicine.
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
For more Information on the report, inquire at http://www.sandlerresearch.org/inquire-before-buying?rname=19073 .
About US:Sandlerresearch.org (http://www.sandlerresearch.org/) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.